Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1996
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074555/ |
id |
pubmed-2074555 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-20745552009-09-10 Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Lösch, A. Kohlberger, P. Gitsch, G. Kaider, A. Breitenecker, G. Kainz, C. Research Article The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma. Nature Publishing Group 1996-06 /pmc/articles/PMC2074555/ /pubmed/8664123 Text en |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Lösch, A. Kohlberger, P. Gitsch, G. Kaider, A. Breitenecker, G. Kainz, C. |
spellingShingle |
Lösch, A. Kohlberger, P. Gitsch, G. Kaider, A. Breitenecker, G. Kainz, C. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
author_facet |
Lösch, A. Kohlberger, P. Gitsch, G. Kaider, A. Breitenecker, G. Kainz, C. |
author_sort |
Lösch, A. |
title |
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
title_short |
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
title_full |
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
title_fullStr |
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
title_full_unstemmed |
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. |
title_sort |
lysosomal protease cathepsin d is a prognostic marker in endometrial cancer. |
description |
The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma. |
publisher |
Nature Publishing Group |
publishDate |
1996 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074555/ |
_version_ |
1611407771623751680 |